A pH/Ultrasound dual-response biomimetic nanoplatform for nitric oxide gas-sonodynamic combined therapy and repeated ultrasound for relieving hypoxia
- PMID: 31785776
- DOI: 10.1016/j.biomaterials.2019.119636
A pH/Ultrasound dual-response biomimetic nanoplatform for nitric oxide gas-sonodynamic combined therapy and repeated ultrasound for relieving hypoxia
Abstract
Sonodynamic therapy (SDT) has rapidly developed as a powerful alternative to traditional photodynamic therapy due to its intrinsically deeper tissue-penetration. However, single SDT dose is incapable of radical cure because the long-term hypoxia of tumor limits its therapeutic effect. Herein, we developed a biomimetic nanoplatform with dual pH/ultrasound response, homologous targeting and low phototoxicity for combined nitric oxide (NO) gas therapy with SDT to solve the problem. This nanoplatform is composed of zeolite imidazole framework-8 material embedded with nitrosoglutathione (GSNO) and chlorin e6 (Ce6) by one-step encapsulation, and then wrapped by homologous tumor cell membrane. In vitro and in vivo experiments indicate that the biomimetic nanoplatform has excellent biocompatibility and shows higher retention in tumor by homologous targeting. Importantly, it can sustainably release the encapsulated drug in acidic tumor microenvironment and accelerate degradation by ultrasound (US). Furthermore, NO released from GSNO and reactive oxygen species generated by Ce6, which are both triggered by US, react with each other to produce highly reactive peroxynitrite to inhibit the growth of tumor. Moreover, by repeated US irradiation, the tumor hypoxia can be relieved for a much-longer term, resulting in an effective gas-sonodynamic combined treatment. This study fully utilizes the advantages of US, providing a new strategy for high-performance cancer therapy.
Keywords: Gas therapy; Metal-organic framework; Nitric oxide; Sonodynamic therapy; Tumor hypoxia relief.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
An Ultrasound-Triggered Nanoplatform for Synergistic Sonodynamic-Nitric Oxide Therapy.ACS Biomater Sci Eng. 2023 Feb 13;9(2):797-808. doi: 10.1021/acsbiomaterials.2c01431. Epub 2023 Jan 20. ACS Biomater Sci Eng. 2023. PMID: 36662809
-
Endogenous H2O2 Self-Replenishment and Sustainable Cascades Enhance the Efficacy of Sonodynamic Therapy.Int J Nanomedicine. 2023 Nov 13;18:6667-6687. doi: 10.2147/IJN.S431221. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38026520 Free PMC article.
-
Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy.Int J Nanomedicine. 2020 Aug 6;15:5687-5700. doi: 10.2147/IJN.S256038. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32821097 Free PMC article.
-
Newly developed gas-assisted sonodynamic therapy in cancer treatment.Acta Pharm Sin B. 2023 Jul;13(7):2926-2954. doi: 10.1016/j.apsb.2022.12.021. Epub 2022 Dec 31. Acta Pharm Sin B. 2023. PMID: 37521874 Free PMC article. Review.
-
Recent progress in nitric oxide-generating nanomedicine for cancer therapy.J Control Release. 2022 Dec;352:179-198. doi: 10.1016/j.jconrel.2022.10.012. Epub 2022 Oct 20. J Control Release. 2022. PMID: 36228954 Review.
Cited by
-
Multiple stimuli-responsive nanosystem for potent, ROS-amplifying, chemo-sonodynamic antitumor therapy.Bioact Mater. 2021 Dec 20;15:355-371. doi: 10.1016/j.bioactmat.2021.12.002. eCollection 2022 Sep. Bioact Mater. 2021. PMID: 35356815 Free PMC article.
-
Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.Theranostics. 2021 Jul 25;11(17):8587-8604. doi: 10.7150/thno.62572. eCollection 2021. Theranostics. 2021. PMID: 34373760 Free PMC article.
-
Application of Nanomaterial-Based Sonodynamic Therapy in Tumor Therapy.Pharmaceutics. 2024 Apr 29;16(5):603. doi: 10.3390/pharmaceutics16050603. Pharmaceutics. 2024. PMID: 38794265 Free PMC article. Review.
-
Biomimetic Metal-Organic Framework Nanoparticles for Synergistic Combining of SDT-Chemotherapy Induce Pyroptosis in Gastric Cancer.Front Bioeng Biotechnol. 2022 Feb 21;10:796820. doi: 10.3389/fbioe.2022.796820. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35265591 Free PMC article.
-
Stimuli Responsive Nitric Oxide-Based Nanomedicine for Synergistic Therapy.Pharmaceutics. 2021 Nov 12;13(11):1917. doi: 10.3390/pharmaceutics13111917. Pharmaceutics. 2021. PMID: 34834332 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources